Biological significance of interventions that change breast density.
Chlebowski
Rowan T
RT
McTiernan
Anne
A
D016588:Anticarcinogenic Agents / Q000494:pharmacology; D001940:Breast / Q000187:drug effects* / Q000473:pathology; D001943:Breast Neoplasms / Q000000981:diagnostic imaging*; D015914:Estrogen Replacement Therapy / Q000009:adverse effects*; D004967:Estrogens / Q000009:adverse effects; D005260:Female; D006801:Humans; D008327:Mammography; D008875:Middle Aged; D011372:Progestins / Q000009:adverse effects; D020849:Raloxifene Hydrochloride / Q000494:pharmacology; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D020845:Selective Estrogen Receptor Modulators / Q000494:pharmacology*; D013629:Tamoxifen / Q000494:pharmacology
D016588:Anticarcinogenic Agents; D004967:Estrogens; D011372:Progestins; D020845:Selective Estrogen Receptor Modulators; D013629:Tamoxifen; D020849:Raloxifene Hydrochloride